Shanghai Fosun Pharmaceutical (Group) Co Ltd (2196.HK) reported a profit for its full year that Increased, from last year
The company's earnings totaled RMB3.371 billion, or RMB1.27 per share. This compares with RMB2.770 billion, or RMB1.04 per share, last year.
The company's revenue for the period rose 1.4% to RMB41.498 billion from RMB40.909 billion last year.
Shanghai Fosun Pharmaceutical (Group) Co Ltd earnings at a glance (GAAP) :
-Earnings: RMB3.371 Bln. vs. RMB2.770 Bln. last year.-EPS: RMB1.27 vs. RMB1.04 last year.-Revenue: RMB41.498 Bln vs. RMB40.909 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.